Eric Ariazi
5Patents
4h-index
12Co-inventors
54Inventor score
Filing activity: Jun 7, 1995 → Feb 11, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5700644A | Identification of differentially expressed genes | Chemistry; Metallurgy | 12 | Expired |
| US7354713B2 | Method of using estrogen-related receptor gamma (ERRγ) status to determine prognosis and treatment strategy for breast cancer, method of using ERRγ as a therapeutic target for treating breast cancer, method of using ERRγ to diagnose breast cancer, and method of using ERRγ to identify individuals predisposed to breast cancer | Physics | 7 | Expired |
| US11681953B2 | Machine learning implementation for multi-analyte assay development and testing | Emerging Cross-Sectional Technologies | 7 | Active |
| US11847532B2 | Machine learning implementation for multi-analyte assay development and testing | Emerging Cross-Sectional Technologies | 4 | Active |
| US7541141B2 | Method of using estrogen-related receptor alpha (ERRα) status to determine prognosis, treatment strategy and predisposition to breast cancer, and method of using ERRα as a therapeutic target for the treatment of breast cancer | Physics | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.